Artificial intelligence integration intensifies within biotech, transforming drug development. Sofinnova partners with NVIDIA to gain AI capabilities enhancing portfolio analytics and discovery. Novo Nordisk accesses Denmark’s Gefion supercomputer for data-intensive AI-driven protein engineering, accelerating therapeutic innovation. Insilico Medicine debuted Nach01, a multimodal foundation model on AWS Marketplace for generative chemistry tasks. These advances emphasize computational power’s critical role in rational molecule design and precision medicine acceleration.